185490 — EyeGene Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for EyeGene, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-8,740	-14,863	-34,569	-26,489	-22,430
Depreciation
Amortisation
Non-Cash Items	-152	2,865	2,089	7,244	-1,387
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-132	1,390	1,406	-613	1,615
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-8,321	-9,754	-30,004	-18,568	-20,065
Capital Expenditures	-1,289	-2,089	-2,827	-906	-1,666
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	12,361	6,540	-53,849	18,155	7,338
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Cash from Investing Activities	11,072	4,451	-56,677	17,249	5,672
Financing Cash Flow Items	9.84	-120	-289	772	491
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	403	4,142	86,624	880	17,853
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	3,153	-1,112	-74	-603	3,450